Pfizer’s COVID-19 Vaccine Approved for Use in Britain
Britain is set to begin administering the first doses of the Pfizer vaccine next week.
- By Nikki Johnson-Bolden
- Dec 08, 2020
Pfizer’s coronavirus vaccine was approved for use in the U.K. on December 2, according to the New York Times.
Britain’s process for authorizing vaccines does not involve the analysis of raw data, as is the case with the FDA in the United States. The differences in protocol made the approval process faster in Britain.
The FDA will hold a meeting on December 10 to review the vaccine. The meeting will be attended by an independent panel of experts.
Distribution plans for the vaccine are similar to the proposed plans in the U.S.—health care workers, nursing home workers and residents and the elderly will receive the vaccine first. 800,000 doses will be shipped to Britain this week.
Nikki Johnson-Bolden is an Associate Content Editor for Occupational Health & Safety.